Live Quote · NASDAQCTNMHealthcare· Biotechnology

Contineum Therapeutics, Inc.

$8.68▼ 3.98%($-0.36)
MKT CAP $306.87MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
80
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTNM research report →

Analyst Price Target
$19.67+126.6% vs. today

Range $17 – $23

Analyst RatingBuy
2 Buy2 Hold0 Sell

Price Chart

-28.97% · this period
$17.57$12.32$7.08Nov 20May 26Nov 20
52-Week Range18% of range
Low
$6.72
Current
$8.68
High
$17.79